The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCizzle Biotech Share News (CIZ)

Share Price Information for Cizzle Biotech (CIZ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.70
Bid: 1.65
Ask: 1.75
Change: 0.00 (0.00%)
Spread: 0.10 (6.061%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.70
CIZ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: WANdisco bookings up; STM legal appeal denied

Mon, 11th Apr 2022 21:14

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Scottish Oriental Smaller Companies Trust PLC – Asia focused investment trust - Says net asset value total return for the six months to February 28 is minus 2.8%, performing better than the MSCI AC Asia ex Japan Small Cap Index which is down by 4.5% during the same period. NAV per share falls 4.7% to 1,204.90 pence at the end of February, from 1,264.54p at the end of August. Its portfolio is most notably lifted by exposure to Taiwanese companies, with key detractors being its holdings in India and Indonesia. Having paid out a dividend of 11.5 pence for the previous financial year ended August 31, it says it is "too early to make a forecast of the distribution for the current financial year". Looking ahead, it forecasts Covid restrictions in China and Hong Kong will hurt the outlook for these regions, but that demand in other countries in Asia will continue to recover, especially in Indonesia and the Philippines.

----------

WANdisco PLC - Sheffield-based data-management software company – Says following a strong influx of orders for its LiveData Migrator product, bookings in the first quarter of the year are USD5.8 million, multiplied year-on-year from USD1.1 million. Ending remaining performance obligations for the period are around USD14 million, over triple that of USD4.2 million in the first quarter of 2021. Says company is "well placed to capture significant market opportunities in high-quality IoT-driven deals and expand into new verticals" into the second half.

----------

Treatt PLC - Bury St Edmunds-based natural extracts and ingredients supplier – Says revenue in its half-year ended March 31 is up 9% year-on-year to GBP66.3 million from GBP60.8 million, as its order book grows in excess of 15% with a "particularly strong pipeline in healthier living, citrus and coffee categories". Expects operating profit and margin to be weighed in its second half, as beverage consumption trends return to normal seasonality. Half-year results will be announced on May 10.

----------

Avingtrans PLC - provides components and systems for the energy, medical and industrial sectors - Wins two new nuclear contracts worth USD7 million for its Hayward Tyler division to be completed by June of next year, with South Korean customer Korea Hydro & Nuclear Power. HT will provide critical nuclear safety-related spare parts to reactors in South Korea. Contracts are of "strategic significance", and show how the potential for HT in the South Korean market, Avingtrans says.

----------

Tiger Royalties and Investments PLC - mining royalty and streaming - Says net portfolio value as of March 31 is 0.20 pence per share, an increase of 11% from 0.18 pence per share at the end of December. Current cash funds at March 31 are GBP22,052.37. Tiger Royalties will next update on quarterly NPV at some point following June 30.

----------

Cizzle Biotechnology Holdings Plc - London-based diagnostics developer – Enters into further 12-month research agreement with the University of York to develop potential applications in cancer diagnosis and therapy, to incorporate Cizzle's proprietary biomarker for cancer detection. Collaboration will begin on June 25, and follows a collaboration announced last September to develop and validate molecular tools for cancers diagnosis and therapy.

----------

Fox Marble Holdings PLC - London-based marble producer – Suspends shares as it arranges GBP400,000 funding by way of a convertible loan note to fund the acquisition of Eco Buildings Group Ltd. Says proposed acquisition will be classed as reverse takeover. Fox Marble will change its name to Eco Buildings Group PLC, as well as re-organise its capital and undertake significant capital expansion. The marble company says any benefits from a successful legal conclusion in the Republic of Kosovo will be structured to only be distributed to current shareholders of Fox Marble. "The Fox Marble business unit within the enlarged group will continue to grow its own business as previously and additionally benefit from supplying its processed marble to the housing manufactured and installed by the Eco Buildings unit," says Chief Executive Officer Christ Gilbert. Shares will resume trading on the publication of an admission document, or until acquisition negotiations are terminated.

----------

STM Group PLC - Isle of Man-based pensions and insurance administrator – Says its application to appeal the judgement of the Court of Appeal in the Adams vs Carey case has been declined, is informed by the Supreme Court. The 2018 case relates to an investment made in 2012 prior to its acquisition of Carey UK Pensions LLP in 2019. "A condition of the acquisition was the indemnity on any claims in the Adams v Carey case, with the benefit of significant existing professional indemnity cover held by the vendors. The decision therefore does not directly impact STM's exposure in this case, but it will have implications for the financial services industry more broadly," the company says.

----------

Prospex Energy PLC - investment company focused on European gas and power projects – Pays EUR2.2 million in consideration and working capital to become 100% owner of UOG Italia Srl, a subsidiary of UOG Holdings PLC. Prospex now holds 37% working interest in the Podere Gallina License, with its ownership of UOG Italia and pre-existing 17% share from its subsidiary PXOG Marshall Ltd. United Oil & Gas says as a result of the sale, it exits the Italian market and is no longer liable for EUR800,000 investment into Selva gas development.

----------

By Elizabeth Winter; elizabethwinter@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
23 Dec 2022 18:15

TRADING UPDATES: Fiinu teams with TransUnion; GRC wins pact

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
23 Nov 2022 16:58

IN BRIEF: Cizzle Biotechnology signs lung-cancer study in China

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - Signs further Memorandum of Understanding with International Co-Innovation Centre for Advanced Medical Technology for a clinical pilot study with the Cancer Hospital Chinese Academy of Medical Sciences, National Cancer Center of China. The clinical pilot study will evaluate optimised assays using a monoclonal antibody that Cizzle Biotechnology has developed that specifically detects CIZ1B, which is highly associated with stage 1 lung cancer.

Read more
9 Nov 2022 20:41

UPDATE: Cizzle, Vela Technologies notes planned Conduit Pharma merger

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - and Vela Technologies PLC - Bradford, England-based investment firm focused on early-stage and pre-IPO disruptive technology investments - Notes announcement by Conduit Pharmaceuticals Ltd that it intends to become a publicly traded company on the Nasdaq in the US through a merger with special purpose acquisition firm Murphy Cannon Acquisition Corp. The deal is expected to generate USD149.7 million worth of proceeds for Conduit.

Read more
28 Sep 2022 14:43

Cizzle Biotechnology reports narrowed loss as passes "key milestones"

(Alliance News) - Cizzle Biotechnology Holdings PLC on Wednesday said it had passed "key milestones" as it moved towards generating revenue for its products.

Read more
18 Aug 2022 11:37

Vela Tech, Cizzle Biotech shares jump on investee's trial results

(Alliance News) - Vela Technologies PLC and Cizzle Biotechnology Holdings PLC on Thursday hailed the latest clinical trial results from investee St George Street Capital Ltd.

Read more
5 Jul 2022 12:15

Cizzle Biotechnology expands use of lung cancer test

(Alliance News) - Cizzle Biotechnology Holdings PLC on Tuesday said that it is using its early-stage lung cancer test technology to detect more cancer types, notably breast cancer.

Read more
20 Jun 2022 15:40

UK shareholder meetings calendar - next 7 days

Tuesday 21 June 
1Spatial PLCAGM
Altus Strategies PLCAGM
Coca-Cola HBC AGAGM
FireAngel Safety Technology Group PLCAGM
HC Slingsby PLCAGM
HSS Hire Group PLCAGM
Mission Group PLCAGM
Novacyt SAAGM
Pendragon PLCAGM
RTW Venture Fund LtdAGM
Velocys PLCAGM
Wednesday 22 June 
ASA International Group PLCAGM
Atalaya Mining PLCAGM
Bonhill Group PLCAGM
Chapel Down Group PLCAGM
Churchill China PLCAGM
Downing Renewables & Infrastructure Trust PLCGM re share issue
Ecofin US Renewables Infrastructure Trust PLCAGM
EJF Investments LtdAGM
Frenkel Topping Group PLCAGM
Good Energy Group PLCAGM
Honeycomb Investment Trust PLCAGM
ICG-Longbow Senior Secured UK Property Debt Investments LtdAGM
Intelligent Ultrasound Group PLCAGM
Iofina PLCAGM
John Wood Group PLCAGM
Kingfisher PLCAGM
LXi REIT PLCGM
Menhaden PLCAGM
North Atlantic Smaller Cos Investment Trust PLCAGM
Pennant International Group PLCAGM
Plant Health Care PLCAGM
Skillcast Group PLCAGM
Team PLCAGM
Tribal Group PLCGM re final dividend
Trident Royalties PLCAGM
Vertu Motors PLCAGM
Wentworth Resources PLCAGM
Thursday 23 June 
Avacta Group PLCAGM
Anglo Asian Mining PLCAGM
Card Factory PLCAGM
Cordiant Digital Infrastructure LtdAGM
Downing Renewables & Infrastructure Trust PLCGM re initial placing & open offer
Eight Capital Partners PLCGM re aligning 2022 bonds with 2026 bonds
GENinCode PLCAGM
Ideagen PLCGM re takeover by Hg Pooled Management Ltd
Longboat Energy PLCAGM
Oxford Nanopore Technologies PLCAGM
Puma VCT 13 PLCGM re cancellation of listing & liquidation
RBG Holdings PLCAGM
Tandem Group PLCAGM
Union Jack Oil PLCAGM
Zinnwald Lithium PLCAGM
Friday 24 June 
AFC Energy PLCGM re fees for non-executive directors
Avast PLCAGM
Devolver Digital IncAGM
Entain PLCAGM
Gulf Keystone Petroleum LtdAGM
Hawkwing PLCAGM
Invesco Bond Income Plus LtdAGM
Life Science REITAGM
Northcoders Group PLCAGM
Princess Private Equity Holding LtdAGM
Monday 27 June 
Anglo-Eastern Plantations PLCAGM
Celadon Pharmaceuticals PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Echo Energy PLCAGM
Medica Group PLCAGM
Pelatro PLCAGM
Surgical Innovations Group PLCAGM
Warpaint London PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
16 Jun 2022 16:55

TRADING UPDATES: Valereum opens NFT market; Conygar considers raising

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
30 May 2022 12:32

IN BRIEF: Cizzle Biotechnology widens annual loss on acquisition costs

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - Posts higher annual loss in 2021. Pretax loss widens to GBP4.0 million from GBP14,000 in 2020. In May 2021, Cizzle was bought by Bould Opportunities PLC. Acquisition-related costs stand at GBP3.1 million in 2021 versus none in 2020.

Read more
6 May 2022 11:18

AIM WINNERS & LOSERS: SDI upbeat; Westminster rises on contract win

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
6 May 2022 10:11

Cizzle Biotechnology shares jump on US lung cancer collaboration

(Alliance News) - Cizzle Biotechnology Holdings PLC on Friday announced a new collaboration into lung cancer testing with a US partner.

Read more
8 Mar 2022 06:45

IN BRIEF: Cizzle Biotech notes promising data from Arcadia study

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - Reports that Arcadia clinical study shows potential value of AZD1656 treatment for Covid-19 patients. The new data analysis comes from St George Street Capital Ltd, which runs the trial with Excalibur Medicines Ltd for the treatment, in which Cizzle holds a "significant" royalty-bearing economic interest.

Read more
14 Feb 2022 15:26

Cizzle Biotechnology acquires further 5% interest in Covid treatment

(Alliance News) - Cizzle Biotechnology Holdings PLC shares jumped on Monday after it announced that it acquired an additional 5% interest in the commercialisation of the Covid-19 treatment AZD 1656.

Read more
3 Feb 2022 22:31

TRADING UPDATES: Alliance Pharma to appeal; Braemar sales to rise

TRADING UPDATES: Alliance Pharma to appeal; Braemar sales to rise

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.